CARING FOR cancer patients
CLINICAL TRIALS OFFICE
The UH Cancer Center ’ s Clinical Trials Office ( CTO ) team remains committed to enhancing diversity , equity , and inclusion through novel clinical trials that meet the needs of cancer patients in Hawai ‘ i and the Pacific . The collective impact of the CTO is underscored by the success of the Tomosynthesis Mammographic Imaging Screening Trial ( TMIST ), a breast screening study comparing 2D vs . 3D mammography . As of December 2023 , CTO has enrolled 500 patients to the TMIST trial , and through collaboration with community health educators continues to focus on increasing the participation of Native Hawaiian and U . S . -Affiliated Pacific Island communities .
In addition , the partnership with FHP Health Center-Guam continues with the goal of opening and conducting clinical trials at this satellite site . In collaboration with the Hawai ‘ i Cancer Consortium partner sites , CTO successfully launched an early phase clinical trial involving a novel therapeutic agent , which has exceeded enrollment expectations . This demonstrates the need for innovative trials locally , and the importance of opening more trials involving novel agents to ensure that our diverse community has access to the most innovative treatment options
CORE VALUE
ACTIVE TRIALS IN 2023 *
HO ‘ OULU , INNOVATION
* Active Trials are studies that were open to enrollment during 2023
closer to home . Lastly , CTO underwent significant changes to revamp the organizational structure and streamline the workflow for study startup , and welcomed new unit leaders and team members to establish a solid foundation to support clinical trials throughout our network .
Our Clinical Trials Office continues to implement improvements to expedite the opening of clinical trials and deliver them promptly , to better serve the community . CTO anticipates exciting developments in the coming years , including the establishment of our Early Phase Clinical Research Center , forming new partnerships locally and abroad , and more . Stay tuned for updates on CTO activities !
PARTICIPANTS RECRUITED IN 2023 BY RESEARCH CATEGORY
Q
Epidemiology , Observational , and Outcomes Studies : 2,315
Q
Therapeutic Trials : 64
Clinical Trials Office Team
5